QuidelOrtho Management
Management criteria checks 1/4
QuidelOrtho's CEO is Brian Blaser, appointed in May 2024, has a tenure of less than a year. directly owns 0.009% of the company’s shares, worth $281.50K. The average tenure of the management team and the board of directors is 1 years and 4.4 years respectively.
Key information
Brian Blaser
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.009% |
| Management average tenure | less than a year |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
QuidelOrtho: Highly Levered With Questionable Growth
Nov 26Lacklustre Performance Is Driving QuidelOrtho Corporation's (NASDAQ:QDEL) Low P/S
Nov 17
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt
Sep 15QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry
Aug 09QuidelOrtho: Attractive Valuation Despite Weak Performance
Apr 13We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt
Apr 08QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues
Feb 15QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate
Mar 13QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Feb 18An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued
Nov 25CEO
Brian Blaser (59 yo)
less than a year
Tenure
Mr. Brian J. Blaser serves as CEO & President at QuidelOrtho Corporation since May 06, 2024 & serves as it's Director since May 15, 2024. He served as an Independent Director at Quanterix Corporation since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 2.7yrs | US$2.94m | 0.018% $ 556.7k | |
| Executive Officer | 10.7yrs | US$2.03m | 0.054% $ 1.7m | |
| President | less than a year | no data | 0.0090% $ 281.5k | |
| Chief Operations Officer | less than a year | no data | 0.0083% $ 258.9k | |
| Executive VP of Research & Development and CTO | less than a year | no data | no data | |
| Vice President of Investor Relations | 1.3yrs | no data | no data | |
| Chief Legal Officer | 4.1yrs | US$3.55m | 0.025% $ 777.6k | |
| Chief Human Resources Officer | less than a year | no data | no data | |
| Point of Care Business Unit Leader | no data | no data | no data | |
| Molecular Diagnostics Business Unit Leader | no data | no data | no data |
1.0yrs
Average Tenure
59yo
Average Age
Experienced Management: QDEL's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | 0.0090% $ 281.5k | |
| Independent Director | 4.4yrs | US$314.47k | 0.012% $ 379.4k | |
| Independent Director | 10.2yrs | US$320.47k | 0.042% $ 1.3m | |
| Independent Non-Executive Chairman | 17.2yrs | US$411.50k | 0.13% $ 4.0m | |
| Independent Director | 6.1yrs | US$326.94k | 0.023% $ 732.8k | |
| Independent Director | 31.9yrs | US$300.95k | 0.035% $ 1.1m | |
| Independent Director | 2.7yrs | US$286.95k | 0.0077% $ 243.2k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 6.8yrs | US$280.00k | 0.044% $ 1.4m | |
| Independent Director | 3.9yrs | US$280.00k | 0.0098% $ 306.9k | |
| Independent Director | less than a year | no data | no data |
4.4yrs
Average Tenure
64.5yo
Average Age
Experienced Board: QDEL's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 04:02 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/29 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
QuidelOrtho Corporation is covered by 24 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Ishan Majumdar | Baptista Research |
| Mark Massaro | Canaccord Genuity |